AU2001291994A1 - Dipeptide ligands of the npff receptor for treating pain and hyperalgesia - Google Patents

Dipeptide ligands of the npff receptor for treating pain and hyperalgesia

Info

Publication number
AU2001291994A1
AU2001291994A1 AU2001291994A AU9199401A AU2001291994A1 AU 2001291994 A1 AU2001291994 A1 AU 2001291994A1 AU 2001291994 A AU2001291994 A AU 2001291994A AU 9199401 A AU9199401 A AU 9199401A AU 2001291994 A1 AU2001291994 A1 AU 2001291994A1
Authority
AU
Australia
Prior art keywords
hyperalgesia
treating pain
npff receptor
dipeptide
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291994A
Inventor
Jean-Jacques Bourguignon
Jean-Paul Macher
Martine Schmitt
Guy Simmonet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FORENAP
Universite Louis Pasteur Strasbourg I
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
FORENAP
Universite Louis Pasteur Strasbourg I
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FORENAP, Universite Louis Pasteur Strasbourg I, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical FORENAP
Publication of AU2001291994A1 publication Critical patent/AU2001291994A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AU2001291994A 2000-09-25 2001-09-25 Dipeptide ligands of the npff receptor for treating pain and hyperalgesia Abandoned AU2001291994A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012164A FR2814367B1 (en) 2000-09-25 2000-09-25 NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA
FR0012164 2000-09-25
PCT/FR2001/002973 WO2002024192A1 (en) 2000-09-25 2001-09-25 Dipeptide ligands of the npff receptor for treating pain and hyperalgesia

Publications (1)

Publication Number Publication Date
AU2001291994A1 true AU2001291994A1 (en) 2002-04-02

Family

ID=8854636

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291994A Abandoned AU2001291994A1 (en) 2000-09-25 2001-09-25 Dipeptide ligands of the npff receptor for treating pain and hyperalgesia

Country Status (3)

Country Link
AU (1) AU2001291994A1 (en)
FR (1) FR2814367B1 (en)
WO (1) WO2002024192A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
WO2004080965A1 (en) * 2003-03-14 2004-09-23 Kyowa Hakko Kogyo Co., Ltd. Neuropeptide ff receptor antagonist
CL2004000553A1 (en) 2003-03-20 2005-02-04 Actelion Pharmaceuticals Ltd USE OF GUANIDINE DERIVATIVE COMPOUNDS AS ANTAGONISTS OF THE FF NEUROPEPTIDE RECEIVER; COMPOUNDS DERIVED FROM GUANIDINA; PREPARATION PROCEDURES; AND PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM.
FI20031454A0 (en) 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selective somatostatin receptor 1 and / or 4 agonists and antagonists
EP2669276A1 (en) 2012-05-31 2013-12-04 Université de Strasbourg Ornithine- and lysine-derivatives for the treatment of pain
KR102375543B1 (en) * 2017-07-21 2022-03-16 스촨 하이스코 파마수티컬 씨오., 엘티디 Peptide amide compounds and methods for their preparation and use in medicine
MX2020008082A (en) 2018-02-05 2020-09-24 Univ Strasbourg Compounds and compositions for the treatment of pain.
JP2022543460A (en) 2019-08-06 2022-10-12 ドメイン・セラピューティクス 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326465A1 (en) * 1993-01-20 1995-02-09 Thomae Gmbh Dr K Amino acid derivatives, pharmaceutical compositions containing these compounds and process for their preparation
GB9500601D0 (en) * 1995-01-12 1995-03-01 Wellcome Found Modified peptides
DE19544686A1 (en) * 1995-11-30 1997-06-05 Thomae Gmbh Dr K Amino acid derivatives, medicaments containing these compounds and processes for their preparation
US6262246B1 (en) * 1998-09-25 2001-07-17 Synaptic Pharmaceutical Corporation DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof

Also Published As

Publication number Publication date
FR2814367A1 (en) 2002-03-29
FR2814367B1 (en) 2008-12-26
WO2002024192A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2281201A (en) Histidine copolymer and methods for using same
AU2001251358A1 (en) Prion-binding ligands and methods of using same
GB2365185A8 (en) Systems and methods for trading
IL146094A0 (en) Diaminothiazoles and their use for inhibiting protein kinases
AU4806100A (en) P element derived vector and methods for its use
AU2001288249A1 (en) Biosensors and methods for their use
AU7989400A (en) Compounds and methods
AU2212299A (en) Compositions and methods for the treatment of tumor
AU4133701A (en) Methods and compositions for peptide synthesis
AU3215500A (en) Compounds and methods
AU6894600A (en) Therapeutic polypeptides and methods for using same
AU4496800A (en) Laminin 2 and methods for its use
AU2001245288A1 (en) Overhanging form system and method of using the same
AU2001280801A1 (en) Mixer and process for use
AU5565099A (en) Pharmaceutical compositions and methods for use
AU7097800A (en) Water treatment systems and methods
AU2001255638A1 (en) Systems and methods for dental treatment planning
AU5724000A (en) Anastomosis system and methods for use
AU2001259817A1 (en) Methods of and compounds for inhibiting calpains
AU2001291994A1 (en) Dipeptide ligands of the npff receptor for treating pain and hyperalgesia
AU4678400A (en) Laminin 8 and methods for its use
AU2001218024A1 (en) Methods for treating and preventing alopecia
AU2566201A (en) Compounds and methods for the treatment of pain
AU2001279090A1 (en) Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases